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ABSTRACT
Data below 1 mm voxel size is getting more and more com-
mon in the clinical practice but it is still hard to obtain a con-
sistent collection of such datasets for medical image process-
ing research. With this paper we provide a large collection of
Contrast Enhanced (CE) Computed Tomography (CT) data
from porcine animal experiments and describe their acqui-
sition procedure and peculiarities. We have acquired three
CE-CT phases at the highest available scanner resolution of
57 porcine livers during induced respiratory arrest. These
phases capture contrast enhanced hepatic arteries, portal ve-
nous veins and hepatic veins. Therefore, we provide scan
data that allows for a highly accurate reconstruction of hep-
atic vessel trees. Several datasets have been acquired during
Radio-Frequency Ablation (RFA) experiments. Hence, many
datasets show also artificially induced hepatic lesions, which
can be used for the evaluation of structure detection methods.
Index Terms— contrast enhanced computed tomography,
liver tumor ablation, porcine study data
1. INTRODUCTION
Contrast Enhanced (CE) Computed Tomography (CT) is a
valuable tool to analyze vascular structures within the body.
*This work is supported by the European Community’s FP7 under grant
agreement no. 223877 (IMPPACT), and 600641 (Go-Smart), coordinated
by Marina Kolesnik. Bernhard Kainz is supported by a Marie Curie Intra-
European Fellowship (FP7-PEOPLE-2012-IEF F.A.U.S.T. 325661).
Arteries and veins, which would be invisible without contrast
agent, show clearly as bright structures after injecting an X-
Ray absorbing iodine-based agent. The contrast agent is usu-
ally administered intravenously and is transported through the
body without significant dissipation for a certain time. This
area of concentrated contrast agent in the blood can be ob-
served moving through the body and is usually called con-
trast agent bolus. A bolus is first transported to the heart,
from where it enters the arterial vessel system. From the ar-
teries the contrast agent perfuses through the body’s tissues
to the veins, which transport it back to the heart. Consecutive
scans, correctly timed after the injection, will therefore show
first bright arteries and then bright veins. The timing of the
scans is crucial for this imaging sequence because the bolus
will only be concentrated for a short period of time and the
contrast agent will distribute evenly through the body shortly
after the injection. This even distribution raises the average
image intensity and, along with the risk of contrast agent in-
toxication, limits the number of times a CE scan can be per-
formed for a single patient.
Usually, the CE scan sequence is triggered automatically by
placing a region of interest (ROI) into a continuously scanned
slice through the subject’s aorta. Previously calculated delays
and amount of contrast agent – depending on the targeted or-
gan and the subject’s body mass – are applied and the scan
sequence is started as soon as the image intensity reaches a
certain threshold in the ROI. Targeting the liver for CE-CT
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Fig. 1. Overview over the datasets. The window-level is adjusted in all images to highlight the discussed features. (a)–(d)
show the target sequence on the example of Pig 36: contrast enhanced arteries (a), contrast enhanced portal veins (b), contrast
enhanced hepatic veins (c), and an overview over this dataset in 3D (d). (e)–(h) show artificially induced RFA lesions for Pig
18 (e), 19 (f), and 34(g) axial and coronal for Pig 34 (h). Note that RFA lesions must not be mistaken with the pig’s gallbladder,
marked in (g) and (h). (i)–(l) show selected specialties of our datasets. RFA lesions may grow together if they have been
induced too close to each other (i) (Pig 43); some experiments took place with an open abdomen of the pig and artificially
injected landmarks (a mixture of tissue glue and CT contrast agent) (j) axial and (k) coronal (Pig 53). Whenever it was possible
we tried to acquire a whole volume within one rotation of the 320 rows CT detector. This reduces motion artifacts and provides
a high resolution but the reconstruction is not completely cubic anymore. The borders of this spiral reconstruction are filled
with the lowest possible intensity values in the image. (l) shows this effect on the example of Pig 14.
vessel tree, the hepatic venous vessel tree, and a hepatic por-
tal venous vessel tree. The portal venous vessel tree conducts
blood from the gastrointestinal tract and spleen to the liver and
will show a higher contrast agent saturation shortly before the
hepatic veins are enriched. We make use of this fact and per-
form three scans after the injection of a contrast agent bolus
in a series of animal experiments. Even though exact sepa-
ration of the portal and hepatic veins is not possible, the two
venous scans show different contrast levels for the two vessel
trees. This differs from clinical practice where only two scans
are performed after bolus injection. The animal experiments
have been performed in the course of the project IMPPACT,
with the goal to develop a patient-specific intervention plan-
ning and monitoring application for Radiofrequency Ablation
(RFA) of malignant liver tumours. RFA is a minimally inva-
sive form of cancer treatment, which is achieved by placing
a needle inside the malignancy and destroying it through in-
tensive heating. Because vessels form a heat-sink [1] during
this procedure, which may allow malicious cancer cells to sur-
vive, highly accurate imaging of the hepatic vessels has been
necessary. Therefore, besides the vessel trees, most of our
scans also show two artificially induced RFA lesions, which
are noticeable by a lower contrast agent saturation.
Related Work: Publicly available hepatic CT dataset are
rare and provide either only a few high-resolution or multi-
model scans [2, 3] or target different organs. The most com-
prehensive publicly available hepatic CT database, which we
are aware of, consists of 10 patient scans [4] and was per-
formed within the acceptable dose and contrast agent limits
for human patients. Because we are providing animal exper-
iment data, we can use a higher dose of contrast agent than
usually allowed in patients. Therefore, our datasets have a
uniquely high contrast and resolution. Furthermore, patients
suffering from hepatocellular carcinoma often show a lower
perfusion in the liver, which lowers the image quality in con-
trast to our mostly healthy pigs.
Our scans are performed in a similar way as proposed by [5],
who presented a way for the correct bolus timing to acquire
data from all three hepatic vessel trees separately.
2. IMAGE ACQUISITION
All authorized animal experiments, including medication,
anaesthesia and euthanasia, have been carried out according
to the Austrian animal law. The pigs have been anaesthetized
by a professional veterinarian using Remifentanyl (Ultivar,
GlaxoSmithKline Pharma GmbH, Vienna, Austria) 1 mg
ad. 50 ml NaCl 0.9% (20 g/ml) 0.08–0.1 g/kg/KG/h and
Sevourane (SEVOfluranr, Abbott Laboratories, Illinois, US)
2% ET. CT scans were performed using a 320 rows Aquilion
One CT System, Toshiba Medical Sytems, (Austria) using
Pig CA art pv hv DENA RFA RFA voxel size max dim comments
[ml] [s] [s] [s] [days] ls. probe x,y,z [mm] x,y,z [voxels]
1 40 5 8 15 – 1 RITA 0.60,0.60,0.50 512,512,320 hv delay too short
2 40 5 15 25 – 2 RITA 0.51,0.51,0.50 512,512,320 –
3 40 5 10 20 – 2 RITA 0.46,0.46,0.50 512,512,320 pv delay too short
4 40 5 15 20 – 2 RITA 0.35,0.35,0.50 512,512,320 –
5 30 5 15 20 – 2 RITA 0.37,0.37,0.50 512,512,320 –
6 30 5 15 20 – 2 RITA 0.38,0.38,0.50 512,512,320 –
7 30 5 15 20 – 2 RITA 0.41,0.41,0.50 512,512,320 –
8 40 5 15 20 – 2 Radionics 0.49,0.49,0.50 512,512,320 –
9 40 5 15 20 – 2 Radionics 0.54,0.54,0.50 512,512,320 –
10 40 5 15 20 35 – – 0.63,0.63,0.30 512,512,734 –
11 40 5 15 20 35 – – 0.63,0.63,0.30 512,512,684 hv delay too long
12 80 5 13 50 307 – – 0.63,0.63,0.30 512,512,901 ∼115 kg weight
13 60 5 8 15 52 – – 0.63,0.63,0.30 512,512,851 pv, hv delay too short
14 40 5 8 15 – 1 RITA 0.50,0.50,0.50 512,512,320 –
15 40 5 8 15 – 2 RITA 0.50,0.50,0.50 512,512,320 –
16 40 5 8 15 – 2 Radionics 0.50,0.50,0.50 512,512,320 low hv contrast
17 40 5 8 15 – 2 Radionics 0.50,0.50,0.50 512,512,320 –
18 40 5 8 15 – 2 RITA 0.45,0.45,0.50 512,512,320 –
19 40 5 8 15 – 2 RITA 0.46,0.46,0.50 512,512,320 1 lesion between lobes (small)
20 40 5 8 15 – 2 RITA 0.45,0.45,0.50 512,512,320 –
21 40 5 8 15 – 2 RITA 0.45,0.45,0.50 512,512,320 low contrast lesions
22 100 5 10 50 258 – – 0.51,0.51,0.30 512,512,531 low hv contrast, ∼150 kg weight
23 100 5 8 15 271 – – 0.67,0.67,0.50 512,512,791 ∼150 kg weight, inflated stomach
24 100 5 8 15 271 – – 0.50,0.50,0.50 512,512,320 ∼150 kg weight
25 40 5 8 15 47 – – 0.50,0.50,0.50 512,512,320 died w/o RFA
26 40 5 15 30 – 2 RITA 0.50,0.50,0.50 512,512,320 –
27 40 5 15 35 – 2 RITA 0.50,0.50,0.50 512,512,320 –
28 40 5 8 15 – – – 0.63,0.63,0.30 512,512,601 moved during scan, low hv contrast
30 40 5 15 50 – 2 RITA 0.50,0.50,0.50 512,512,320 –
31 40 5 15 50 – 2 RITA 0.50,0.50,0.50 512,512,320 –
34 40 5 15 50 – 2 RITA 0.63,0.63,0.30 512,512,634 –
35 40 5 15 50 – 2 RITA 0.51,0.51,0.30 512,512,607 –
36 40 5 13 35 – 2 RITA 0.51,0.51,0.30 512,512,674 –
37 40 5 13 25 – 2 RITA 0.52,0.52,0.30 512,512,681 –
38 40 5 15 25 – 2 RITA 0.51,0.51,0.30 512,512,581 –
39 40 5 15 25 – 2 RITA 0.51,0.51,0.30 512,512,561 –
40 40 5 15 25 – 2 RITA 0.47,0.47,0.30 512,512,754 –
41 40 5 15 25 – 2 RITA 0.54,0.54,0.30 512,512,754 –
42 40 5 15 25 – 2 RITA 0.51,0.51,0.30 512,512,647 –
43 40 5 15 25 – 2 RITA 0.54,0.54,0.30 512,512,607 –
44 100 5 15 25 272 – – 0.71,0.71,0.30 512,512,867 low pv, hv contrast, ∼150 kg weight
45 40 5 15 25 – 2 RITA 0.63,0.63,0.30 512,512,594 –
46 40 5 15 25 – 2 RITA 0.63,0.63,0.30 512,512,587 –
47 110 5 15 25 309 – – 0.66,0.66,0.30 512,512,681 low pv, hv contrast,∼180 kg weight
48 110 5 15 25 355 – – 0.63,0.63,0.30 512,512,614 ∼180 kg weight
53 40 5 15 25 – 1 RITA 0.53,0.53,0.30 512,512,694 open abdomen with CE landmarks
56 40 5 15 25 239 – – 0.70,0.70,0.30 512,512,914 low hv contrast
57 40 5 15 25 146 – – 0.72,0.72,0.30 512,512,1007 low hv contrast, died w/o RFA
58 40 5 15 25 – 1 RITA 0.63,0.63,0.30 512,512,607 open abdomen with CE landmarks
59 40 5 15 25 – 1 RITA 0.57,0.57,0.30 512,512,757 open abdomen, low hv contrast
60 40 5 15 25 158 2 RITA 0.50,0.50,0.30 512,512,607 high DENA dose
61 40 5 15 25 138 1 RITA 0.69,0.69,0.30 512,512,821 high DENA dose, CE landmarks, low hv
62 40 5 15 25 291 2 RITA 0.67,0.67,0.30 512,512,867 high DENA dose
63 40 5 15 25 120 – – 0.70,0.70,0.30 512,512,821 high DENA dose, low hv contrast
64 40 5 15 25 242 2 RITA 0.69,0.69,0.30 512,512,947 high DENA dose, low hv contrast
97 40 5 15 50 – – – 0.63,0.63,0.30 512,512,634 low hv contrast
98 40 5 15 50 – – – 0.63,0.63,0.30 512,512,651 –
Table 1. Summary of the available datasets. We use our own experiment IDs as identifier of the datasets (Pig) to keep
consistency with our database. These IDs are also used as name scheme in the downloadable datasets. In this table we also give
information on the amount of used contrast agent (CA), which mainly depends on the animal’s weight, the used scan delay for
the arterial (art), portal-venous (pv) and hepatic-venous (hv) CE scans, the time of the exposure to DENA (DENA), the number
of RFA lesions (RFA ls.) and the used RFA probe, together with the dimensions of the datasets and further comments for special
cases. The weight of the animals has been between 35 and 55 kg, unless otherwise stated.
120kV , 250mAs, a body standard FC 17 reconstruction
filter, and a helical pitch of 53. For the scan and during anaes-
thesia the pig has been artificially ventilated and placed in a
plastic laundry basket to stabilize its position.
For RFA research, a radiologist inserted an RFA probe (RITA
StarBurstr XL, Electrosurgical Device, RITA Medical Sys-
tem, CA, US or Radionics Cool-tip, Covidien Surgical So-
lutions Group, CO, US) into the liver during respiratory ar-
rest under image guidance and induced a 3–5 cm large le-
sion. This procedure has been repeated once in most of the
cases to get two separate lesions at previously defined posi-
tions. At the end of the procedure, a 3-phase CE-CT scan was
performed using 40-110 ml contrast agent under artificial res-
piratory arrest. The three contrast phases have been acquired
after placing a ROI into the pig’s continuously scanned aorta.
As soon as the image intensity exceeded a predefined thresh-
old, the image sequence has been triggered according to the
delays given in Table 1. We have configured the scanner to ac-
quire images at the highest available resolution for the given
field of view. The scan volume has been adjusted by a radio-
grapher to cover the whole liver. Depending on the animal’s
size, the scan volume can either fit within the 160 mm detec-
tor array of the scanner, which allows to reconstruct a whole
512×512×320 voxels volume per rotation with 0.5mm slice
distance after one 0.5s rotation of the detector array (spiral re-
construction), or, for larger scan areas, several rotations with
0.5mm × 64slices have been used internally by the scanner
to reconstruct a larger volume with a lower slice distance of
0.3mm. The in-plane resolution depends also on the chosen
scan volume and has been adjusted to be as high as possi-
ble. The feed-head direction of the animal in the scanner has
been chosen depending on the planned experiment, i.e., some
scans can appear upside down. We have also tried to induce
cirrhosis and hepatocellular carcinomas by injections of N-
Nitrosodiethylamine (DENA) once a week. That means that
some of our scan data show different levels of cirrhosis and
therefore different perfusion levels. The time of DENA expo-
sure is also summarized in Table 1.
3. APPLICATIONS
The datasets are available online1 and Figure 1 shows selected
annotated slices of the resulting scans. The data has been
used for various applications. In [6] we could show that our
datasets allow for vessel segmentation with an error less than
one voxel. [7, 8] discuss how to use these datasets for access
path decision support for minimal invasive interventions and
[9] use the segmentation results from these datasets to build a
model for RFA ablations, which is able to accurately predict
the cooling effect of vessels during the RFA procedure.
The datasets are collected in separate rar-compressed archives.
Each archive contains three contrast phases per pig. The files
are saved in nifti format [10] for the widest possible com-
1http://www.gosmart-project.eu/datasets.php
patibility. The original scan resolution and orientation are
contained in the header section of each nii-file.
4. CONCLUSIONS
We have presented a database of 57 high resolution hepatic
CE-CT scans from a porcine RFA study. These datasets can
be freely used for research in medical image processing and
visualization and allows evaluation of these algorithms for
image quality that is not yet available for human patients.
We believe that our datasets will help to develop novel tech-
niques and that as much value as possible can be gained from
the scarification of the animals. In future we plan to amend
the data with expert segmentations of the liver.
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